Nicole Strittmatter (*1987) is an analytical chemist and expert in mass spectrometry. She joined the Faculty of Chemistry as a Professor of Analytical Chemistry in October 2021.

The research interests of her group are metabolomics/lipidomics, in situ and ambient mass spectrometry, imaging mass spectrometry (MSI), and multimodal, multi-'omics' data integration. Her research group develops and utilises these methods to advance our understanding of complex biological systems. In particular, they are developing strategies to characterise the spatial heterogeneity of microbial biofilms at the microscopic and macroscopic levels for medical, environmental, and biotechnological applications and the analysis of tissues of preclinical and clinical origin.

Prof. Strittmatter studied chemistry at the Justus Liebig University in Gieβen. She received her Ph.D. from Imperial College London, UK, in the Division of Computational and Systems Medicine, Department of Surgery and Cancer. She obtained her Ph.D. degree in analytical chemistry in 2016 for the development of novel in situ mass spectrometric methods for the characterisation of unicellular organisms such as bacteria, yeasts, and cell lines. Furthermore, she used DESI-MSI to analyse clinical cancer samples.

From 2015 to 2021, she worked as a Senior Scientist (from 2019 onwards Associate Principal Scientist) in imaging mass spectrometry at AstraZeneca's R&D center in Cambridge, UK. There, she used DESI and MALDI MSI and imaging mass cytometry (IMC) to study drugs, their delivery to target tissues, and their pharmacodynamic effects. She has worked primarily in the area of characterising the impact of nanomedicine formulations on drug distribution. Furthermore, she serves as Eection Editor Imaging for the Journal of Mass Spectrometry & Advances In The Clinical Lab (JMASCL) since December 2020.